| Patents for C07C 401 - Irradiation products of cholesterol or its derivatives; Vitamin d derivatives, 9,10-seco cyclopenta[a]phenanthrene or analogues obtained by chemical preparation without irradiation (3,426) |
|---|
| 08/17/2006 | US20060183716 High binding to vitamin D receptors; intestinal calcium transport activity; psoriasis; leukemia; anticarcinogenic agents; multiple sclerosis; lupus; antidiabetic agents; host versus graft/organ reaction; antiinflammatory agents; rheumatoid arthritis; asthma; inflammatory bowel disease; skin/bone disorder |
| 08/17/2006 | US20060183185 Method for the synthesis of astaxanthin |
| 08/17/2006 | CA2597568A1 2-methylene-19-nor-(20s-24epi)-1.alpha.,25-dihydroxyvitamin-d2 |
| 08/16/2006 | CN1269808C Process for the preparation of vialoguestamin D analogs |
| 08/10/2006 | US20060178538 Methods for the synthesis of chiral dihydroxy intermediates useful for the chiral synthesis of carotenoids |
| 08/10/2006 | US20060178351 Treatment of immune-mediated disorders with active vitamin D compounds alone or in combination with other therapeutic agents |
| 08/10/2006 | US20060178350 7-(2-Cyclohexylidene-ethylidene)-spiro[4.5]decanes |
| 08/09/2006 | EP1688409A1 Vitamin d-derived monohalogenovinyl compounds |
| 08/03/2006 | WO2006057932A3 2-METHYLENE-18,19-DINOR-1α-HYDROXY-HOMOPREGNACALCIFEROL AND ITS USES |
| 08/02/2006 | EP1685099A1 Crystalline forms of 1,24(s)-dihiyproxy vitamin d2 |
| 08/02/2006 | CN1267394C Vitamin D analogues |
| 07/27/2006 | WO2005067673A3 Enzymatic method to produce 7-dehydropregnenolone, vitamin d3-like compounds and derivatives thereof |
| 07/27/2006 | US20060167319 Methods for the synthesis of unsaturated ketone intermediates useful for the synthesis of carotenoids |
| 07/27/2006 | US20060166949 Vitamin d analogues, compositions comprising said analogues and their use |
| 07/25/2006 | CA2289209C Cyclic ether vitamin d3 compounds, 1.alpha. (oh) 3-epi-vitamin d3 compounds and uses thereof |
| 07/20/2006 | US20060160779 2,2-Di-substituted 1alpha,25-dihydroxy-19-norvitamin d derivative |
| 07/20/2006 | US20060160769 And protected derivatives; arrests the proliferation of undifferentiated cells and induces their differentiation to monocytes; treating cancer, skin disorders, autoimmune disorders, inflammatory conditions, obesity and renal osteodystrophy |
| 07/19/2006 | CN1805750A Treatment of immune-mediated disorders with active vitamin D compounds alone or in combination with other therapeutic agents |
| 07/18/2006 | CA2227938C Novel vitamin d analogues |
| 07/13/2006 | WO2006057915A3 2-methylene-19,21-dinor-1alpha-hydroxy-bishomopregnacalciferol |
| 07/13/2006 | WO2006057902A3 2alpha-methyl-19-nor-1alpha-hydroxy-homopregnacalciferol and its uses |
| 07/13/2006 | WO2006057901A3 2-METHYLENE-19-NOR-1α-HYDROXY-17-ENE-HOMOPREGNACALCIFEROL AND ITS USES |
| 07/13/2006 | US20060155150 Methods for the synthesis of lutein |
| 07/13/2006 | CA2593982A1 Prevention of thrombotic disorders with active vitamin d compounds or mimics thereof |
| 07/12/2006 | EP1677802A2 1,3 aclyated 24-keto-vitamin d3 compounds and methods of use thereof |
| 07/12/2006 | CN1802349A Treatment of lung cancer with active vitamin D compounds in combination with other treatments |
| 07/11/2006 | US7074777 Vitamin D derivatives |
| 07/11/2006 | CA2283829C 2-alkylidene-19-nor-vitamin d compounds |
| 07/06/2006 | WO2006071129A1 Process for preparation of a pharmaceutical grade calcipotriol anhydrous |
| 07/06/2006 | WO2006057900A3 17,20(z)-dehydro vitamin d analogs and their uses |
| 07/06/2006 | WO2006057899A3 2alpha-methyl-19-nor-(20s)-1alpha-hydroxy-bishomopregnacalciferol and its uses |
| 07/06/2006 | WO2005079464A3 Vitamin d receptor antagonists and their use in treating asthma |
| 07/06/2006 | US20060148759 2alpha-methyl-19-nor-1alpha-hydroxy-homopregnacalciferol and its uses |
| 07/04/2006 | US7071344 Vitamin D derivatives with cyclopropyl rings in the lateral chains, a method and intermediate products for the production thereof and the utilization thereof for producing medicaments |
| 07/04/2006 | US7071179 Method of locking 1α-OH of vitamin D compounds in axial orientation |
| 07/04/2006 | US7071178 Bone disorders; osteoporosis |
| 06/29/2006 | WO2006057886A3 2-METHYLENE-19,26,27-TRINOR-(20S)-1α-HYDROXYVITAMIN D3 AND ITS USES |
| 06/29/2006 | WO2006057885A3 17,20(e)-dehydro vitamin d analogs and their uses |
| 06/29/2006 | US20060142246 2-Methylene-19,26,27-trinor-(20S)-1alpha-hydroxyvitamin D3 and its uses |
| 06/22/2006 | US20060135800 2-Methylene-19,21-dinor-1alpha-hydroxy-bishomopregnacalciferol |
| 06/22/2006 | US20060135799 2-Methylene-19-NOR-(20R)-1alpha-hydroxy-bishomopregnacalciferol |
| 06/22/2006 | US20060135798 2-Methylene-19-nor-(20S)-1alpha-hydroxy-trishomopregnacalciferol |
| 06/22/2006 | US20060135493 Use of 2-methylene-19-nor-20(S)-1alpha,25-dihydroxyvitamin D3 to increase bone strength |
| 06/22/2006 | US20060135492 Use of 2-methylene-19-nor-20(S)-1alpha,25-dihydroxyvitamin D3 to increase bone strength |
| 06/22/2006 | US20060135491 Vitamin D3 analog useful for the treatment of osteoporosis |
| 06/20/2006 | US7064115 (20S)-1α-hydroxy-2α-methyl and 2β-methyl-19-nor-vitamin D3 and their uses |
| 06/20/2006 | CA2142204C A vitamin d derivative with substituent at the 2.beta.-position |
| 06/08/2006 | WO2006059768A1 9,10-secopregnane derivative and medicine |
| 06/08/2006 | US20060122157 2-Methylene-18,19-dinor-1alpha-hydroxy-homopregnacalciferol and its uses |
| 06/07/2006 | EP1663250A1 Methods for treating bladder dysfunction |
| 06/07/2006 | EP1663249A1 1,3-DIACLYATED,26,27-ALKYL/HALOALKYL VITAMIN D sb 3 /sb COMPOUNDS AND METHODS OF USE THEREOF |
| 06/06/2006 | US7056904 Therapy for bone disorders; osteoporosis; vitamin deficiency |
| 06/01/2006 | WO2006057932A2 2-METHYLENE-18,19-DINOR-1α-HYDROXY-HOMOPREGNACALCIFEROL AND ITS USES |
| 06/01/2006 | WO2006057915A2 2-methylene-19,21-dinor-1alpha-hydroxy-bishomopregnacalciferol |
| 06/01/2006 | WO2006057914A2 2-methylene-19-nor-(20s)-1alpha-hydroxy-trishomopregnacalciferol |
| 06/01/2006 | WO2006057913A2 2-METHYLENE-19-NOR-(20R)-1-α-HYDROXY-BISHOMOPREGNACALCIFEROL |
| 06/01/2006 | WO2006057902A2 2alpha-methyl-19-nor-1alpha-hydroxy-homopregnacalciferol and its uses |
| 06/01/2006 | WO2006057901A2 2-METHYLENE-19-NOR-1α-HYDROXY-17-ENE-HOMOPREGNACALCIFEROL AND ITS USES |
| 06/01/2006 | WO2006057900A2 17,20(z)-dehydro vitamin d analogs and their uses |
| 06/01/2006 | WO2006057899A2 2alpha-methyl-19-nor-(20s)-1alpha-hydroxy-bishomopregnacalciferol and its uses |
| 06/01/2006 | WO2006057886A2 2-METHYLENE-19,26,27-TRINOR-(20S)-1α-HYDROXYVITAMIN D3 AND ITS USES |
| 06/01/2006 | WO2006057885A2 17,20(e)-dehydro vitamin d analogs and their uses |
| 06/01/2006 | WO2006057884A2 2α-METHYL AND 2ß-METHYL ANALOGS OF 19,26,27-TRINOR-(20S)-1α-HYDROXYVITAMIN D3 AND THEIR USES |
| 06/01/2006 | US20060116352 2alpha-Methyl and 2beta-methyl analogs of 19,26,27-trinor-(20S)-1alpha-hydroxyvitamin D3 and their uses |
| 06/01/2006 | US20060116351 17,20(Z)-dehydro vitamin D analogs and their uses |
| 06/01/2006 | CA2588412A1 2alpha-methyl-19-nor-1alpha-hydroxy-homopregnacalciferol and its uses |
| 06/01/2006 | CA2588406A1 2-.alpha.-methyl and 2-.beta.-methyl analogs of 19,26,27-trinor-(20s-1.alpha.-hydroxyvitamin d3 and their uses |
| 06/01/2006 | CA2588401A1 17,20(z)-dehydro vitamin d analogs and their uses |
| 06/01/2006 | CA2588399A1 2alpha-methyl-19-nor-(20s)-1alpha-hydroxy-bishomopregnacalciferol and its uses |
| 06/01/2006 | CA2588396A1 17,20(e)-dehydro vitamin d analogs and their uses |
| 06/01/2006 | CA2588060A1 2-methylene-19-nor-(20s)-1alpha-hydroxy-trishomopregnacalciferol |
| 06/01/2006 | CA2588038A1 2-methylene-19-nor-(20r)-1-.alpha.-hydroxy-bishomopregnacalciferol |
| 05/30/2006 | US7053075 Methods for reducing body fat using vitamin D compounds |
| 05/26/2006 | WO2006053985A1 Novel method for preparing 3-[5'-(3,4-bis-hydroxymethyl-benzyloxy)-2'- ethyl-2-propyl-biphenyl-4-yl]-penta-3-ol |
| 05/26/2006 | CA2584790A1 Novel method for preparing 3-[5'-(3,4-bis-hydroxymethyl-benzyloxy)-2'- ethyl-2-propyl-biphenyl-4-yl]-penta-3-ol |
| 05/25/2006 | US20060111580 Methods for the synthesis of chiral dihydroxy ketone intermediates useful for the chiral synthesis of carotenoids |
| 05/25/2006 | US20060111330 17,20(E)-dehydro vitamin D analogs and their uses |
| 05/25/2006 | US20060111321 And protected derivatives; arrests the proliferation of undifferentiated cells and induces their differentiation to monocytes; treating cancer, skin disorders, autoimmune disorders, inflammatory conditions, obesity and renal osteodystrophy |
| 05/18/2006 | WO2006052066A1 Process for preparing 1-alpha-hydroxycholecalciferol derivatives |
| 05/17/2006 | EP1656157A1 2-methylene-19-nor-vitamin d2 compounds |
| 05/17/2006 | CN1774242A Methods for preparation and use of 1alpha,24(s)-dihydroxyvitamin d2 |
| 05/16/2006 | CA2147264C Vitamin d derivatives and a process for producing them |
| 05/10/2006 | EP0924199B1 Crystals of vitamin d derivatives and process for the preparation thereof |
| 05/10/2006 | CN1771226A 2-propylidene-19-nor-vitamin d compounds |
| 05/09/2006 | CA2141652C Fluorinated vitamin d3 derivative |
| 05/03/2006 | CN1765883A Photochemical synthesis preparation method for vitamin D2 |
| 05/03/2006 | CN1765882A Water soluble vitamins D2 preparation method |
| 04/27/2006 | WO2006042383A1 Vitamin-d analogue useful in a pharmaceutical composition |
| 04/27/2006 | US20060088905 Methods for the synthesis of zeazanthin |
| 04/27/2006 | US20060088904 Methods for the synthesis of astaxanthin |
| 04/20/2006 | WO2006039763A1 Vitamin d3 analogues for the prevention and treatment of bone disorders |
| 04/13/2006 | WO2006039685A2 Methods for synthesis of chiral intermediates of carotenoids, carotenoid analogs, and carotenoid derivatives |
| 04/12/2006 | CN1758916A Method of treating and preventing hyperparathyroidism with vitamin D2 or D4 compounds |
| 04/12/2006 | CN1250225C Use of 2alpha-methyl-19-nor-20(s)-1alpha, 25-dihydroxyvitamin d3 to increase bone strength |
| 04/06/2006 | WO2006036813A2 20-cycloalkyl,26,27-alkyl/haloalkyl vitamin d3 compounds and methods of use thereof |
| 04/06/2006 | US20060074255 3-Methyl-20-epi-vitamin D derivatives |
| 04/05/2006 | EP1641467A1 (20s)-1alpha-hydroxy-2-methylene-19-nor-vitamin d3 and its uses |
| 04/05/2006 | EP1641466A1 2-methylene-19-nor-20(s)-25-methyl-1alpha-hydroxycalciferol and its uses |
| 04/05/2006 | EP0981514B1 3-epi vitamin d2 compounds and uses thereof |
| 04/04/2006 | CA2222785C Vitamin d analogues |